newsfilter
← Latest News
ClinicalTrials.gov·

YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma - NCT05448820

Phase 1: Determine recommended phase 2 dose of YH001 in combination with Envafolimab, Phase 1: Determine recommended phase 2 dose of YH001 in combination with Envafolimab with Doxorubicin, Phase 2: Determine the objective response rate (ORR) of YH001 in combination with Envafolimab and Doxorubicin, (and 15 more...)